As an alternative diagnosis approach [16] for diagnosis of gastrinoma it was recommended that a positive diagnosis could be made by using a combination of suggested clinical symptoms and elevated FSG level with the presence of a duodenal/pancreatic NET with gastrin expression by immunohistochemistry or the presence of positive uptake on somatostatin receptor imaging (SRI). Here, GAST is linked to gastrin-producing neuroendocrine tumor.